Because the antioxidant bypasses your digestive system completely, it is immediately available for your cells to absorb and use
Scientific References Holst JJ, Madsbad S
To summarize the open-label extension of VESPER-1, berobenatide 2.4 mg weekly demonstrated 16% weight loss at 32 weeks, a favorable benefit-risk profile for monthly dosing, and safety and tolerability consistent with the class with no discontinuations related to gastrointestinal adverse events, and the gastrointestinal tolerability was excellent, said John B
Since it does not require the action of dihydrofolate reductase for its conversion, its function as a vitamin is unaffected by inhibition of this enzyme by drugs such as methotrexate
Fragments of mitochondrial DNA released into the extracellular space or circulation, typically during cellular stress, necrosis or mitochondrial damage